Author:
Kenley Richard A.,Bancroft Fred,L'Italien James,Stepanenko Anna,Townsend Michael,Dixit Trupti
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference15 articles.
1. Young A, Pittner R, Gedulin B, Vine W, Rink T. Amylin Regulation of carbohydrate metabolism. Biochem Soc Trans. 1995;23:325–331.
2. Scherbaum WA. The role of amylin in the physiology of glycemic control. Experimental and Clinical Endocrinol and Diabetes. 1998:106(2):97–102.
3. Amiel S. Amylin and diabetes. Lancet. 1993:341:1249–1250.
4. Janes S, Gaeta L, Beaumont K, Beeley K, Rink T. The selection of pramlintide for clinical evaluation. Diabetes. 1996;45 (Suppl 2): 235A.
5. Thompson RG, Gottlieb A, Organ K, Kolterman OG. Pramlintide, a human amylin analog reduced post-prandial plasma glucose, insulin and epeptide concentrations in patients with type II diabetes. Diabetic Medicine. 1997;14(7):547–555.